Biogen US Locations: A Gateway to Innovative Research and Development

Biogen, a global biotechnology leader, has a strong presence in the United States with multiple locations across the country, including research and development centers, manufacturing facilities, and commercial offices. Our commitment to scientific discovery and patient care is evident in each of our US locations, where we are actively driving innovation and improving the lives of people with serious neurological and rare diseases.

Expansion into the US and Global Reach

Biogen's presence in the US began in 1989 with the establishment of its headquarters in Cambridge, Massachusetts. Since then, the company has expanded its footprint across the nation, with locations in California, North Carolina, and Massachusetts. With a workforce of over 9,000 employees in the US, Biogen is a major employer and a significant contributor to the life sciences industry.

State	Number of Locations	Key Activities
Massachusetts	6	Headquarters, research and development, manufacturing
California	3	Research and development, commercial operations
North Carolina	2	Manufacturing, supply chain

Research and Innovation Hubs

Biogen's research and development centers in the US are at the forefront of scientific discovery. The company's scientists are pushing the boundaries of neuroscience, immunology, and other therapeutic areas, leading to the development of groundbreaking treatments for neurological disorders such as multiple sclerosis, Alzheimer's disease, and spinal muscular atrophy.

Research Center	Location	Focus Areas
Biogen Idec Research Center	Cambridge, MA	Neuroscience, immunology, rare diseases
Center for Advanced Science	Cambridge, MA	Drug discovery, biomarker development
Biogen Research Laboratories	Waltham, MA	Immunology, neurodegenerative diseases

Manufacturing Excellence

Biogen's manufacturing facilities in the US play a crucial role in delivering high-quality therapies to patients worldwide. The company's state-of-the-art manufacturing sites adhere to the highest industry standards and are equipped with cutting-edge technologies. Biogen's commitment to manufacturing excellence ensures a reliable supply of safe and effective treatments for patients in need.

Manufacturing Facility	Location	Products Manufactured
Biogen Manufacturing	RTP, NC	Multiple sclerosis therapies, Alzheimer's disease therapies
Biogen Aliso Viejo	Aliso Viejo, CA	Immunology therapies, rare disease therapies
Biogen BioProcess Development	Framingham, MA	Research and development of manufacturing processes

Patient-Centered Approach

At Biogen, we are deeply committed to improving the lives of patients with neurological and rare diseases. Our US locations serve as centers of excellence for patient care and support. Biogen's patient advocacy programs, research initiatives, and educational resources empower patients and their families to navigate the challenges of living with complex diseases.

Success Stories

Multiple Sclerosis: Biogen's treatment for multiple sclerosis has helped over 2.5 million patients worldwide, reducing disease progression and improving quality of life.

Alzheimer's Disease: Biogen's recently approved treatment for Alzheimer's disease is the first therapy to demonstrate a reduction in clinical decline in patients with early-stage disease.

Spinal Muscular Atrophy: Biogen's gene therapy for spinal muscular atrophy has provided hope and improved outcomes for patients with this devastating disease.

Conclusion

Biogen's US locations are a testament to the company's unwavering commitment to scientific innovation, manufacturing excellence, and patient care. Through our dedicated research and development efforts, state-of-the-art manufacturing facilities, and patient-centered approach, Biogen is transforming the lives of people with serious neurological and rare diseases.

Biogen US Locations: A Gateway to Innovative Research and Development